These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 9583864)
1. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients. Ontañón J; Muro M; García-Alonso AM; Minguela A; Torío A; Bermejo J; Pons JA; Campos M; Alvarez-López MR Transplantation; 1998 Apr; 65(8):1047-53. PubMed ID: 9583864 [TBL] [Abstract][Full Text] [Related]
2. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Mañez R; White LT; Linden P; Kusne S; Martin M; Kramer D; Demetris AJ; Van Thiel DH; Starzl TE; Duquesnoy RJ Transplantation; 1993 May; 55(5):1067-71. PubMed ID: 8388584 [TBL] [Abstract][Full Text] [Related]
3. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients. Herzberg GZ; Rossi AF; Courtney M; Gelb BD J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760 [TBL] [Abstract][Full Text] [Related]
4. Influence of human leukocyte antigen mismatching on rejection development and allograft survival in liver transplantation: is the relevance of HLA-A locus matching being underestimated? Muro M; López-Álvarez MR; Campillo JA; Marin L; Moya-Quiles MR; Bolarín JM; Botella C; Salgado G; Martínez P; Sánchez-Bueno F; López-Hernández R; Boix F; Bosch A; Martínez H; de la Peña-Moral JM; Pérez N; Robles R; García-Alonso AM; Minguela A; Miras M; Alvarez-López MR Transpl Immunol; 2012 Mar; 26(2-3):88-93. PubMed ID: 22129495 [TBL] [Abstract][Full Text] [Related]
5. Association of human cytomegalovirus viremia with human leukocyte antigens in liver transplantation recipients. Hu J; Meng X; Zhao H; Zhang X; Gao H; Yang M; Ma Y; Li M; Ma W; Fan J Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):576-81. PubMed ID: 21680603 [TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus infection in renal transplant recipients: one center's experience. Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948 [TBL] [Abstract][Full Text] [Related]
8. Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation. Mañez R; White LT; Kusne S; Martin M; Demetris AJ; Starzl TE; Duquesnoy RJ Transplant Proc; 1993 Feb; 25(1 Pt 2):908-9. PubMed ID: 7680170 [No Abstract] [Full Text] [Related]
9. Role of Human Leukocyte Antigen Compatibility in Graft Outcomes After Living Donor Liver Transplantation. Shin M; Kim JM; Kwon CH; Kim SJ; Joh JW Transplant Proc; 2016 May; 48(4):1123-9. PubMed ID: 27320571 [TBL] [Abstract][Full Text] [Related]
10. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database. Navarro V; Herrine S; Katopes C; Colombe B; Spain CV Liver Transpl; 2006 Apr; 12(4):652-8. PubMed ID: 16555339 [TBL] [Abstract][Full Text] [Related]
11. Acute rejection of hepatic allografts from HLA-DR13 (Allele DRB1(*)1301)-positive donors. Oertel M; Berr F; Schröder S; Schwarz R; Tannapfel A; Wenzke M; Lamesch P; Hauss J; Kohlhaw K Liver Transpl; 2000 Nov; 6(6):728-33. PubMed ID: 11084059 [TBL] [Abstract][Full Text] [Related]